CoChat
Sign Up
Cited by 66Antifungal resistance and susceptibilityFungal Infections and StudiesYeasts and Rust Fungi Studies

Characterization of the differential pathogenicity of Candida auris in a Galleria mellonella infection model

Open access
Garcia-Bustos, Victor, Ruiz-Saurí, Amparo, Ruiz-Gaitán, Alba, Sigona-Giangreco, Ignacio Antonio, Cabañero-Navalon, Marta Dafne, Sabalza-Baztán, Oihana, Salavert-Lletí, Miguel, Tormo, María Ángeles +1 more·2021·Microbiology Spectrum
DOI 10.1128/spectrum.00013-21PMC PMC8552516
Open this paper in CoChat — free account

Abstract

Candida auris is an emergent fungus that has become a global threat due to its multidrug resistance, mortality, and transmissibility. These unique features make it different from other Candida species, but we still do not fully know the degree of virulence and, especially, the host-pathogen interactions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/spectrum.00013-21

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. [1]Ruiz-Gaitan A, Martinez H, Moret AM, Calabuig E, Tasias M, Alastruey-Izquierdo A, Zaragoza O, Mollar J, Frasquet J, Salavert-Lleti M, Ramirez P, Lopez-Hontangas JL, Peman J. 2019. Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients. Expert Rev Anti Infect Ther 17: 295– 305. doi: 10.1080/14787210.2019.1592675. 30922129 · DOI
  2. [2]Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. 2017. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64: 134– 140. doi: 10.1093/cid/ciw691. 27988485 PMC5215215 · DOI · Paper page
  3. [3]Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, Griffiths D, George S, Butcher L, Morgan M, Newnham R, Sunderland M, Clarke T, Foster D, Hoffman P, Borman AM, Johnson EM, Moore G, Brown CS, Walker AS, Peto TEA, Crook DW, Jeffery KJM. 2018. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 379: 1322– 1331. doi: 10.1056/NEJMoa1714373. 30281988 · DOI · Paper page
  4. [4]Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. 2009. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53: 41– 44. doi: 10.1111/j.1348-0421.2008.00083.x. 19161556 · DOI · Paper page
  5. [7]Ruiz-Gaitan A, Moret AM, Tasias-Pitarch M, Aleixandre-Lopez AI, Martinez-Morel H, Calabuig E, Salavert-Lleti M, Ramirez P, Lopez-Hontangas JL, Hagen F, Meis JF, Mollar-Maseres J, Peman J. 2018. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses 61: 498– 505. doi: 10.1111/myc.12781. 29655180 · DOI · Paper page
  6. [8]Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP. 2017. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol 55: 2996– 3005. doi: 10.1128/JCM.00921-17. 28747370 PMC5625385 · DOI · Paper page
  7. [9]Iguchi S, Itakura Y, Yoshida A, Kamada K, Mizushima R, Arai Y, Uzawa Y, Kikuchi K. 2019. Candida auris: a pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains. J Infect Chemother 25: 743– 749. doi: 10.1016/j.jiac.2019.05.034. 31257156 · DOI
  8. [11]Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF. 2019. Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis 25: 1780– 1781. doi: 10.3201/eid2509.190686. 31310230 PMC6711235 · DOI · Paper page
  9. [12]Brennan M, Thomas DY, Whiteway M, Kavanagh K. 2002. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 34: 153– 157. doi: 10.1111/j.1574-695X.2002.tb00617.x. 12381467 · DOI
  10. [13]Borman AM. 2018. Of mice and men and larvae: Galleria mellonella to model the early host-pathogen interactions after fungal infection. Virulence 9: 9– 12. doi: 10.1080/21505594.2017.1382799. 28933671 PMC5955190 · DOI
  11. [14]Borman AM, Szekely A, Johnson EM. 2016. Comparative pathogenicity of united kingdom isolates of the emerging pathogen Candida auris and other key pathogenic Candida species. mSphere 1: e00189-16. doi: 10.1128/mSphere.00189-16. 27547827 PMC4990711 · DOI · Paper page
  12. [15]Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R. 2017. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis 23: 328– 331. doi: 10.3201/eid2302.161320. 28098553 PMC5324806 · DOI · Paper page
  13. [16]Romera D, Aguilera-Correa JJ, Garcia-Coca M, Mahillo-Fernandez I, Vinuela-Sandoval L, Garcia-Rodriguez J, Esteban J. 2020. The Galleria mellonella infection model as a system to investigate the virulence of Candida auris strains. Pathog Dis 78: ftaa067. doi: 10.1093/femspd/ftaa067. 33098293 · DOI
  14. [17]Munoz JE, Ramirez LM, Dias LDS, Rivas LA, Ramos LS, Santos ALS, Taborda CP, Parra-Giraldo CM. 2020. Pathogenicity levels of colombian strains of Candida auris and Brazilian strains of Candida haemulonii species complex in both murine and Galleria mellonella experimental models. J Fungi 6: 104. doi: 10.3390/jof6030104. PMC7558079 32664191 · DOI
  15. [18]Hirayama T, Miyazaki T, Ito Y, Wakayama M, Shibuya K, Yamashita K, Takazono T, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H. 2020. Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation. Sci Rep 10: 3814. doi: 10.1038/s41598-020-60792-y. 32123235 PMC7052222 · DOI
  16. [19]Bravo Ruiz G, Ross ZK, Gow NAR, Lorenz A. 2020. Pseudohyphal growth of the emerging pathogen Candida auris is triggered by genotoxic stress through the S phase checkpoint. mSphere 5: e00151-20. doi: 10.1128/mSphere.00151-20. 32161147 PMC7067593 · DOI · Paper page
  17. [20]Yue H, Bing J, Zheng Q, Zhang Y, Hu T, Du H, Wang H, Huang G. 2018. Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch. Emerg Microbes Infect 7: 188. doi: 10.1038/s41426-018-0187-x. 30482894 PMC6258701 · DOI · Paper page
  18. [21]Alfouzan W, Dhar R, Albarrag A, Al-Abdely H. 2019. The emerging pathogen Candida auris: a focus on the Middle-Eastern countries. J Infect Public Health 12: 451– 459. doi: 10.1016/j.jiph.2019.03.009. 31000491 · DOI
  19. [22]Larkin E, Hager C, Chandra J, Mukherjee PK, Retuerto M, Salem I, Long L, Isham N, Kovanda L, Borroto-Esoda K, Wring S, Angulo D, Ghannoum M. 2017. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 61: e02396-16. doi: 10.1128/AAC.02396-16. 28223375 PMC5404565 · DOI · Paper page
  20. [23]Munoz JF, Gade L, Chow NA, Loparev VN, Juieng P, Berkow EL, Farrer RA, Litvintseva AP, Cuomo CA. 2018. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun 9: 5346. doi: 10.1038/s41467-018-07779-6. 30559369 PMC6297351 · DOI · Paper page
  21. [25]Perdoni F, Falleni M, Tosi D, Cirasola D, Romagnoli S, Braidotti P, Clementi E, Bulfamante G, Borghi E. 2014. A histological procedure to study fungal infection in the wax moth Galleria mellonella. Eur J Histochem 58: 2428. doi: 10.4081/ejh.2014.2428. 25308852 PMC4194400 · DOI
  22. [26]Ames L, Duxbury S, Pawlowska B, Ho HL, Haynes K, Bates S. 2017. Galleria mellonella as a host model to study Candida glabrata virulence and antifungal efficacy. Virulence 8: 1909– 1917. doi: 10.1080/21505594.2017.1347744. 28658597 PMC5750810 · DOI
  23. [27]Frenkel M, Mandelblat M, Alastruey-Izquierdo A, Mendlovic S, Semis R, Segal E. 2016. Pathogenicity of Candida albicans isolates from bloodstream and mucosal candidiasis assessed in mice and Galleria mellonella. J Mycol Med 26: 1– 8. doi: 10.1016/j.mycmed.2015.12.006. 26852192 · DOI
  24. [28]Gago S, Garcia-Rodas R, Cuesta I, Mellado E, Alastruey-Izquierdo A. 2014. Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella. Virulence 5: 278– 285. doi: 10.4161/viru.26973. 24193303 PMC3956503 · DOI
  25. [29]Mesa-Arango AC, Forastiero A, Bernal-Martinez L, Cuenca-Estrella M, Mellado E, Zaragoza O. 2013. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast. Med Mycol 51: 461– 472. doi: 10.3109/13693786.2012.737031. 23170962 · DOI
  26. [31]Chybowska AD, Childers DS, Farrer RA. 2020. Nine things genomics can tell us about Candida auris. Front Genet 11: 351. doi: 10.3389/fgene.2020.00351. 32351544 PMC7174702 · DOI
  27. [32]Forgacs L, Borman AM, Prepost E, Toth Z, Kardos G, Kovacs R, Szekely A, Nagy F, Kovacs I, Majoros L. 2020. Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model. Emerg Microbes Infect 9: 1160– 1169. doi: 10.1080/22221751.2020.1771218. 32486923 PMC7448943 · DOI · Paper page
  28. [33]Marcos-Zambrano LJ, Bordallo-Cardona MA, Borghi E, Falleni M, Tosi D, Munoz P, Escribano P, Guinea J. 2020. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella. Med Mycol 58: 83– 92. doi: 10.1093/mmy/myz027. 30874807 · DOI · Paper page
  29. [34]Monroy-Perez E, Paniagua-Contreras GL, Rodriguez-Purata P, Vaca-Paniagua F, Vazquez-Villasenor M, Diaz-Velasquez C, Uribe-Garcia A, Vaca S. 2016. High virulence and antifungal resistance in clinical strains of Candida albicans. Can J Infect Dis Med Microbiol 2016: 5930489. doi: 10.1155/2016/5930489. 28058052 PMC5183749 · DOI
  30. [35]Romera D, Aguilera-Correa JJ, Gadea I, Vinuela-Sandoval L, Garcia-Rodriguez J, Esteban J. 2019. Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs. J Med Microbiol 68: 1353– 1358. doi: 10.1099/jmm.0.001036. 31271350 · DOI
  31. [36]Garcia-Bustos V, Salavert M, Ruiz-Gaitan AC, Cabanero-Navalon MD, Sigona-Giangreco IA, Peman J. 2020. A clinical predictive model of candidaemia by Candida auris in previously colonized critically ill patients. Clin Microbiol Infect 26: 1507– 1513. doi: 10.1016/j.cmi.2020.02.001. 32061792 · DOI
  32. [38]Staniszewska M. 2020. Virulence factors in Candida species. Curr Protein Pept Sci 21: 313– 323. doi: 10.2174/1389203720666190722152415. 31544690 · DOI
  33. [39]Azar MM, Turbett SE, Fishman JA, Pierce VM. 2017. Donor-derived transmission of Candida auris during lung transplantation. Clin Infect Dis 65: 1040– 1042. doi: 10.1093/cid/cix460. 28520901 · DOI
  34. [40]Brand A. 2012. Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol 2012: 517529. doi: 10.1155/2012/517529. 22121367 PMC3216317 · DOI
  35. [41]Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R, Meis JF, Armstrong-James D, Fisher MC. 2016. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5: 35. doi: 10.1186/s13756-016-0132-5. 27777756 PMC5069812 · DOI · Paper page
  36. [42]Fan S, Yue H, Zheng Q, Bing J, Tian S, Chen J, Ennis CL, Nobile CJ, Huang G, Du H. 2021. Filamentous growth is a general feature of Candida auris clinical isolates. Med Mycol. doi: 10.1093/mmy/myaa116. PMC8257410 33485272 · DOI · Paper page

Cited by

Sorted by citations

Authors
Garcia-Bustos, V., Ruiz-Saurí, A., Ruiz-Gaitán, A., Sigona-Giangreco, I. A., Cabañero-Navalon, M. D., Sabalza-Baztán, O., Salavert-Lletí, M., Tormo, M. Á., & Pemán, J.
Affiliations
  • Department of Internal Medicine and Infectious Diseases, University and Polytechnic La Fe Hospital, Valencia, Spain
  • Department of Pathology, Faculty of Medicine and Dentistry, University of Valencia, Valencia, Spain
  • Severe Infection Research Group, Health Research Institute La Fe, Valencia, Spain
  • Hospital Universitari i Politècnic La Fe (ES)
ORCID
Venue
Microbiology Spectrum
Publisher
American Society for Microbiology
Published
2021-09-03
Volume
9
Issue
1
Pages
e0001321-e0001321
ISSN
2165-0497 (ISSN-L)
DOI
10.1128/spectrum.00013-21
PMC
PMC8552516
OpenAlex
W3168790032
Cited by
66
References
7
Citations by year
2026: 12 · 2025: 14 · 2024: 16 · 2023: 11 · 2022: 8 · 2021: 5
FWCI
3.17
Type
journal article
Language
en
Open access
Licence
Locations
  • Microbiology Spectrum (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
MEC | Instituto de Salud Carlos III (PI17_01538)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
Keywords
Candida auris, Galleria mellonella, fungal pathogenicity, disseminated fungal infection, host-pathogen interaction
MeSH terms
Candida auris, Animals, Candidiasis, Disease Models, Animal, Larva, Moths, Phenotype, Virulence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review